Research and development costs are a common justification for high cancer drug prices and a new study published by JAMA Internal Medicine offers an updated estimate of the spending needed to bring a drug to the U.S. market.
Sep 11, 2017
Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage III BRAF-mutant melanoma, according to late-breaking results from the COMBI-AD trial presented today ...
Sep 11, 2017
Adjuvant nivolumab is superior to standard of care ipilimumab in patients with surgically resected stage III/IV melanoma who are at high risk of relapse, according to late-breaking results from the CheckMate 238 trial presented ...
Sep 11, 2017
A study involving cardiac patients at the University Hospital of Umeå shows that over 80 percent of patients treated for atrial fibrillation also have sleep apnea - a condition with pauses in breathing during sleep. The ...
Sep 11, 2017
Researchers have developed a technique to accurately isolate fetal heart sounds from background noise in acoustic recordings, allowing them to distinguish between different segments of the fetal heartbeat. This technique ...
Sep 11, 2017
Nurses in Portugal began a five-day strike over status, pay and working hours on Monday, crippling services at public hospitals, union leaders said.
Sep 11, 2017
French health inspectors have found one poultry farm with eggs tainted by the insecticide fipronil out of 2,900 which have been checked in the wake of the Europe-wide scandal, France's farm minister said Monday.
Sep 11, 2017
